Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Bayer credits Aspirin, Aleve for consumer gains; Vitamin Shoppe thinking small with new stores; DSM nutrition grows on volume, Martek performance; more Sales & Earnings In Brief.
You may also be interested in...
Sales & Earnings In Brief
Bayer Consumer exec will lead expansion
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.